Nectar Lifescience Financials

NSE: NECLIFE | BSE: 532649

₹9.81

up-down-arrow ₹-0.17 (-1.70%)

As on 20-Nov-2026IST

Market cap

info icon

₹192 Cr

Revenue (TTM)

info icon

₹2 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.3

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
1.74
--
--
1,684.09
1,523.67
1,668.83
Total Income
25.67
10.64
10.41
1,701.14
1,576.73
1,680.15
Total Expenditure
94.85
60.70
0.19
1,532.53
1,470.66
1,510.29
EBITDA
-93.11
-60.70
-0.19
151.55
53.01
158.54
Depreciation
0.37
0.34
0.62
60.72
59.12
56.97
EBIT
-93.48
-61.05
-0.81
90.84
-6.11
101.57
Interest
36.28
37.48
8.53
89.62
89.37
78.81
Other Income
23.93
10.64
10.41
17.06
53.06
11.32
Exceptional Items
88.15
--
--
--
--
--
Profit before Tax
-17.68
-87.88
1.07
18.27
-42.42
34.08
Provision for Tax
-35.93
-30.53
0.38
13.27
-18.24
9.03
Profit after Tax
18.26
-57.35
0.70
5.00
-24.18
25.05
Minority Interest
--
--
--
--
--
--
Share of Associate
--
--
--
--
--
--
Consolidated Profit
-66.33
-292.89
-113.68
5.00
-24.18
25.05

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
569.62
582.30
956.11
1,069.25
1,064.59
1,087.91
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
11.50
-215.28
14.54
141.51
213.12
296.29
Current Liabilities
20.21
26.05
1,021.54
972.82
890.93
1,003.83
Total Liabilities
601.33
621.61
2,047.22
2,191.06
2,189.21
2,390.83

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
334.88
108.31
754.60
899.75
937.46
1,033.18
Current Assets
235.30
252.97
1,237.59
1,283.83
1,231.18
1,354.85
Total Assets
601.33
621.61
2,047.22
2,191.06
2,189.21
2,390.83
Total Debt*
--
--
582.02
635.54
753.83
859.93
Net Current Assets
215.08
226.92
216.05
311.02
340.26
351.02
Contingent Liabilities
--
229.52
101.95
198.18
161.45
75.65

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
-348.72
169.44
224.69
133.65
95.01
Cash Flow from Investing Activities
--
1,208.15
-41.93
-17.03
51.70
16.64
Cash from Financing Activities
--
-766.51
-128.09
-205.44
-185.58
-119.38
Net Cash Inflow / Outflow
--
92.91
-0.58
2.23
-0.23
-7.73

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
-0.52
-15.08
-5.07
0.22
-1.08
1.12
Cash EPS (₹) info
-3.41
-2.93
0.06
2.93
1.56
3.66
Adjusted Book Value (₹) info
29.32
29.98
42.63
47.68
47.47
48.51
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
--
-17.95
7.56
10.02
5.96
4.24
Free Cash Flow per Share (₹) info
--
8.19
9.42
4.69
3.69
-0.33

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
-4.75
0.59
6.12
2.49
5.77
ROE (%) info
-0.69
-7.46
0.07
0.47
-2.25
2.33
ROA (%) info
1.51
-4.80
0.03
0.23
-1.06
1.05
EBIT Margin (%) info
-5,362.88
--
--
5.39
-0.40
6.09
Net Margin (%) info
71.12
-538.87
6.70
0.29
-1.53
1.49
Cash Profit Margin (%) info
0.00
--
--
3.41
2.00
4.26

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
138.11
--
-100.00
10.53
-8.70
8.13
EBIT Growth (%) info
-51,259.89
-7,473.82
-100.89
1,586.17
-106.02
146.53
Net Profit Growth (%) info
-872.11
-8,327.69
-86.05
120.66
-196.55
134.19
EPS Growth (%) info
78.21
-197.43
-2,376.25
120.65
-196.54
134.19
Book Value Growth (%) info
--
-39.10
-10.58
0.44
-2.14
2.44

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
-19.21
--
--
135.18
--
21.53
Price / Book Value info
0.34
0.31
0.54
0.63
0.33
0.50
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
-1.11
-1.37
105.53
7.66
10.30
8.13
Close Price (₹) info
10.50
9.30
22.95
30.15
15.95
24.05
High Price (₹) info
22.49
28.27
56.50
45.70
34.20
48.40
Low Price (₹) info
9.20
9.30
21.85
14.36
14.36
18.55
Market Cap (₹ Cr) info
192.32
--
--
675.32
355.62
539.37

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
--
--
0.61
0.59
0.71
0.79
Short term debt to equity ratio info
--
--
0.46
0.39
0.43
0.46
Current Ratio info
11.64
9.71
1.21
1.32
1.38
1.35
Quick Ratio info
11.64
9.70
0.54
0.59
0.63
0.69
Interest Coverage info
0.51
-1.34
1.13
1.20
0.53
1.43

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
--
--
--
22.52
18.35
26.78
Asset Turnover info
0.00
--
--
0.89
0.77
0.81
Receivable days info
--
--
--
62.43
75.92
77.89
Inventory Days info
--
--
--
130.94
139.23
118.26
Payable days info
--
--
--
112.09
109.47
107.25
Cash Conversion Cycle info
--
--
--
81.28
105.68
88.90
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month